Search

everythinglearnresearchcommunity

for

Search:↓

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Low SHBG levels are linked to negative health outcomes and should be used in assessing and managing health conditions.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Lower SHBG levels may increase the risk of PCOS.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Sex hormones may affect COVID-19 severity and outcomes.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

PCOS affects multiple organs and requires combined treatment with lifestyle changes, metformin, and oral contraceptives.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Early-onset male baldness may increase the risk of metabolic syndrome.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Sex hormones affect liver fat and metabolic health differently in men and women.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Testosterone is vital for male health, and its deficiency is linked to aging and common health issues.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Retinoic acid affects male and female muscle energy use and function differently.

Probiotics may help improve health markers in women with PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Hair loss, known as androgenetic alopecia, is mainly caused by genetics, but also by hormone imbalances, shrinking hair follicles, inflammation, and environmental factors.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.